Tectonic Therapeutic (TECX) Retained Earnings (2017 - 2025)
Tectonic Therapeutic (TECX) reported Retained Earnings of -$222.7 million for Q4 2025, down 2474955.56% year-over-year from N/an in Q4 2024, and down 9.45% quarter-over-quarter from -$203.5 million in Q3 2025.
Tectonic Therapeutic (TECX) Retained Earnings (2017 - 2025) Analysis & Trends
Tectonic Therapeutic (TECX) has 9 years of Retained Earnings data on file, last reported at -$222.7 million in Q4 2025.
- Retained Earnings for Q4 2025 came in at -$222.7 million, down 2474955.56% year-over-year; the trailing twelve-month figure through Dec 2025 was -$222.7 million (down 2474955.56% YoY), and the FY2025 annual result was -$222.7 million, down 2474955.56% from the prior year.
- Retained Earnings fell to -$222.7 million in Q4 2025 per TECX's latest filing, from -$203.5 million in the prior quarter.
- Over five years, Retained Earnings peaked at $9000.0 in Q4 2024 and troughed at -$514.4 million in Q1 2023.
- A 5-year average of -$281.0 million and a median of -$339.0 million in 2021 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings surged 181.82% in 2024, then tumbled 2474955.56% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$383.5 million in 2021, then dropped by 27.61% to -$489.4 million in 2022, then surged by 100.0% to -$11000.0 in 2023, then soared by 181.82% to $9000.0 in 2024, then plunged by 2474955.56% to -$222.7 million in 2025.
- Business Quant data shows TECX's Retained Earnings at -$222.7 million in Q4 2025, -$203.5 million in Q3 2025, and -$49000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -838.07 Mn |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -222.74 Mn |
| Sep 30, 2025 | -203.50 Mn |
| Jun 30, 2025 | -49,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | -77,000.00 |
| Jun 30, 2024 | -118.50 Mn |
| Mar 31, 2024 | -484.08 Mn |
| Dec 31, 2023 | -11,000.00 |
| Sep 30, 2023 | -468.49 Mn |
| Jun 30, 2023 | -446.91 Mn |
| Mar 31, 2023 | -514.39 Mn |
| Dec 31, 2022 | -489.43 Mn |
| Sep 30, 2022 | -464.40 Mn |
| Jun 30, 2022 | -441.43 Mn |
| Mar 31, 2022 | -413.38 Mn |
| Dec 31, 2021 | -383.54 Mn |
| Sep 30, 2021 | -355.32 Mn |
| Jun 30, 2021 | -322.70 Mn |
| Mar 31, 2021 | -291.32 Mn |